Genentech and Cyprotex logo new size

Webinar Series | A Focus on Drug Transporters

 

Investigating Protein-Facilitated Uptake of OATP Substrates: From In Vitro Data to PBPK Modeling

 

The fourth and final webinar in this series on drug transporters was presented by Christine Bowman from Genentech.


About the Webinar

 

Christine will discuss the concept of protein-facilitated uptake and the recently proposed hypothesis of a transporter-induced protein binding shift. In vitro data generated with hepatocytes and HEK293 cells will be described as well as the results of using the HEK293 data for input in PBPK models.  The results suggest that high affinity binding to transporters may change the equilibrium of nonspecific binding between drugs and plasma proteins, leading to greater cellular uptake and clearance than currently predicted. 

 


About the Speaker

 

Christine Bowman

 

 Christine Bowman PhD
Associate Scientist, DMPK | Genentech

Christine Bowman is an Associate Scientist in the Drug Metabolism and Pharmacokinetics Department at Genentech, Inc.  Her research interests include improving in vitro to in vivo extrapolation with new in vitro methods and PBPK modeling.  Prior to Genentech, Christine received her PhD from the University of California, San Francisco in the laboratory of Dr. Leslie Benet during which time she was the recipient of a National Science Foundation Graduate Research Fellowship and PhRMA Foundation Pre-Doctoral Fellowship in Pharmaceutics.  Christine is an author and coauthor of 16 peer-reviewed scientific publications.


Watch the webinar